{"altmetric_id":4690792,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )"],"first_seen_on":"2015-10-28T13:53:11+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1416852292,"links":["http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02298946?lup_d=14&lup_s=11%2F10%2F2014&no_unk=Y&recr=Open&sel_rss=mod14&show_rss=Y&term=cancer","http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02298946?lup_d=30&lup_s=10%2F25%2F2014&recr=Open&term=cancer"],"nct_id":"NCT02298946","pubdate":"2014-11-21T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy in People With Metastatic Colorectal Cancer","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":5032658,"mean":5.9650115992388,"rank":4190857,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":5032658,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":189577,"mean":10.100416687766,"rank":148954,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":189577,"percentile":1},"this_journal":{"total_number_of_other_articles":13245,"mean":5.0504329507702,"rank":11379,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":13245,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":691,"mean":6.2982463768116,"rank":560,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":691,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}},"geo":{"twitter":{"US":1}}},"counts":{"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["GoToPER"],"posts_count":1}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/GoToPER\/status\/536943547438465024","license":"datasift","citation_ids":[4690792],"posted_on":"2014-11-24T18:04:52+00:00","author":{"name":"PER","url":"http:\/\/gotoper.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3438723869\/2416df847bccb4c5ad8da6015ba30370_normal.jpeg","description":"Physicians' Education Resource (PER) specializes in oncology and hematology CME-certified activities. We advance cancer care through professional education.","id_on_source":"GoToPER","tweeter_id":"37703552","geo":{"lt":40.31622,"ln":-74.51376,"country":"US"},"followers":4420},"tweet_id":"536943547438465024"}]}}